Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35M
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
13.1M
-
Shares change
-
-4.05M
-
Total reported value, excl. options
-
$17.8M
-
Value change
-
-$10.5M
-
Put/Call ratio
-
0
-
Number of buys
-
11
-
Number of sells
-
-33
-
Price
-
$1.36
Significant Holders of Apyx Medical Corp - Common Stock (APYX) as of Q1 2024
68 filings reported holding APYX - Apyx Medical Corp - Common Stock as of Q1 2024.
Apyx Medical Corp - Common Stock (APYX) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.1M shares
of 35M outstanding shares and own 37.36% of the company stock.
Largest 10 shareholders include Archon Capital Management LLC (3.45M shares), ROYCE & ASSOCIATES LP (2.44M shares), VANGUARD GROUP INC (1.48M shares), Taylor Frigon Capital Management LLC (638K shares), Silverberg Bernstein Capital Management LLC (621K shares), HORIZON KINETICS ASSET MANAGEMENT LLC (615K shares), BlackRock Inc. (500K shares), COMMONWEALTH EQUITY SERVICES, LLC (497K shares), GEODE CAPITAL MANAGEMENT, LLC (316K shares), and GREENWOOD CAPITAL ASSOCIATES LLC (286K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.